Groups

Fund universe
View all funds
Groups A-Z
Group name
Fund universe
View funds in this group

News & Research

PIMCO

Eight equity ‘super veterans’ all investors should know

Matteo Anelli
18 September 2025
Experts reveal the equity fund managers who have endured different investing cycles.

Don’t be fooled by the UK’s doomsday preppers

William Tamworth
17 September 2025
It sometimes feels like everyone else in the UK is readying themselves for an impending economic apocalypse.

The only two expensive UK funds that have justified their higher costs

Patrick Sanders
17 September 2025
No funds in the IA UK All Companies sector paired top-quartile returns with an OCF of above 1%.

Why these UK trust managers have ditched alcohol and pharmaceutical stocks

Patrick Sanders
16 September 2025
Three stockpickers outline where the most opportunities and risks are in the UK market.

The unloved asset class that has smashed the S&P 500

15 September 2025

Do you need an active UK equity fund?

12 September 2025

Artemis Alpha Manager: ‘Interest rates remaining at 4% is not sensible’

11 September 2025

Fundswire

The opportunity gap in Asia

Baillie Gifford
17 September 2025
Read more

Are high yield bonds still attractive despite low credit spreads?

Liontrust Asset Management
16 September 2025
Read more

The AI infrastructure buildout

Liontrust Asset Management
15 September 2025
Read more

Back to school.

Premier Miton
15 September 2025
Read more

The best of data, the worst of data

Liontrust Asset Management
12 September 2025
Read more

Performance Tables

Contact Details

25 Cabot Square, Canary Wharf, London, England, E14 4QA

44 0 20 7425 8000

http://www.morganstanley.com

msim_intermediary_uksales@morganstanley.com

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.